ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 26 filers reported holding ASCENDIS PHARMA A/S in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $642,000 | -28.2% | 6,863 | -31.5% | 0.00% | – |
| Q2 2023 | $894,000 | +735.5% | 10,013 | +901.3% | 0.00% | – |
| Q1 2023 | $107,000 | -18.3% | 1,000 | -6.2% | 0.00% | – |
| Q4 2022 | $131,000 | -15.5% | 1,066 | -29.1% | 0.00% | – |
| Q3 2022 | $155,000 | -32.6% | 1,503 | -39.2% | 0.00% | – |
| Q2 2022 | $230,000 | -18.1% | 2,474 | +3.6% | 0.00% | – |
| Q1 2022 | $281,000 | +26.0% | 2,389 | +44.2% | 0.00% | – |
| Q4 2021 | $223,000 | -35.4% | 1,657 | -23.5% | 0.00% | – |
| Q3 2021 | $345,000 | +41.4% | 2,166 | +16.7% | 0.00% | – |
| Q2 2021 | $244,000 | +5.6% | 1,856 | +3.9% | 0.00% | – |
| Q1 2021 | $231,000 | -11.2% | 1,787 | +14.6% | 0.00% | – |
| Q4 2020 | $260,000 | +31.3% | 1,560 | +21.6% | 0.00% | – |
| Q3 2020 | $198,000 | +9.4% | 1,283 | +4.8% | 0.00% | – |
| Q2 2020 | $181,000 | +79.2% | 1,224 | +36.0% | 0.00% | – |
| Q1 2020 | $101,000 | -19.2% | 900 | 0.0% | 0.00% | – |
| Q4 2019 | $125,000 | +42.0% | 900 | -1.6% | 0.00% | – |
| Q3 2019 | $88,000 | -17.0% | 915 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | 0.0% | 915 | +1.7% | 0.00% | – |
| Q1 2019 | $106,000 | +68.3% | 900 | -10.0% | 0.00% | – |
| Q4 2018 | $63,000 | -11.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $71,000 | – | 1,000 | +33233.3% | 0.00% | – |
| Q2 2018 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 4 | -78.9% | 0.00% | – |
| Q4 2017 | $1,000 | – | 19 | +216.7% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 6 | -85.7% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 42 | -77.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |